NL-OMON28533尚未招募不适用
Fase I/II trial with melphalan for percutaneous chemosaturation (CS-PHP-Mephalan) in treating irresectable liver metastases
eiden University Medical Centre0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 34
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Liver metastases of histologically confirmed primary colorectal adenocarcinoma;
- •- Resection of primary tumor > 1 month before IHP;
排除标准
- •Biological age <18 and >65 years
- •- WHO performance status ≥ 2 (Appendix A);
研究者
相似试验
招募中
2 期
Fase I/II trial with melphalan for percutaneous chemosaturation (CS-PHP-Mephalan) in treating irresectable liver metastasesNL-OMON41379eids Universitair Medisch Centrum36
已完成
2 期
Phase II trial with melphalan for percutaneous chemosaturation (CS-PHP-Mephalan) in treating unresectable liver metastases of uveal melanomaNL-OMON44964eids Universitair Medisch Centrum34
Unknown
1 期
Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell TumorsCentral Nervous System Embryonal NeoplasmEmbryonal Tumor With Multilayered Rosettes, C19MC-AlteredMedulloblastomaMedulloepitheliomaPrimitive Neuroectodermal TumorRecurrent Childhood Central Nervous System Embryonal NeoplasmRecurrent Malignant Germ Cell TumorRecurrent MedulloblastomaRecurrent Primitive Neuroectodermal TumorGerm Cell TumorNCT00983398OHSU Knight Cancer Institute17
已完成
1 期
Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell TransplantationPlasma Cell MyelomaNCT03417284M.D. Anderson Cancer Center62
已完成
2 期
Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for LymphomaHodgkin DiseaseLymphoma, Non-HodgkinNCT01969435Washington University School of Medicine50